Related Experiment Video
Updated: Jul 15, 2025

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
New Treatments for Acromegaly in Development
Mônica R Gadelha1,2,3, Ana Carolina Gadelha1, Leandro Kasuki1,2
1Endocrine Unit and Neuroendocrinology Research Center, Medical School and Hospital Universitário Clementino Fraga Filho-Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-913, Brazil.
New acromegaly treatments are emerging to improve efficacy and convenience for patients resistant to current therapies. These advancements aim to address unmet needs in managing this rare hormonal disorder.
Area of Science:
- Endocrinology
- Pharmacology
Background:
- Acromegaly treatment has advanced significantly, yet a subset of patients remain uncontrolled.
- Current therapies present challenges in efficacy and patient treatment burden.
Purpose of the Study:
- To review the evolving landscape of acromegaly treatments.
- To highlight the need for improved therapeutic options for difficult-to-control acromegaly.
Main Methods:
- Literature review of recent advancements in acromegaly pharmacotherapy.
- Analysis of emerging treatment modalities and their potential benefits.
Main Results:
- Several novel therapeutic agents are under development for acromegaly.
- These new treatments show promise for increased efficacy and improved patient convenience.
Conclusions:
- Ongoing research is crucial for developing more effective acromegaly treatments.
- Future therapies may offer better disease control and reduce the treatment burden for patients.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Alzheimer's Disease: Treatment

